Although the exact mechanisms underlying the protective role of magnesium in NAFLD, T2DM, and MetS are unknown (78), the observed health benefits are likely associated with magnesium involvement in numerous metabolic pathways, particularly insulin action and glucose metabolism (30, 80). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.